Abstract
Results of different radiotherapy schedules used for early stage (T1-2, N0-1, M0) cutaneous T-cell lymphoma (CTCL) are compared in a series of 45 patients (22 patients treated with high dose total skin electron beam therapy (TSEB) with curative intent, 18 patients treated with palliative radiotherapy, and 5 patients treated with high dose local electron beam). At 3, 5, and 10 years after diagnosis the high dose TSEB treatment group had a probability of overall survival of 91%, 86%, and 75%, respectively, compared with 94%, 88%, and 88% for the palliative treatment group. The complete response (CR) rate for the high dose TSEB treatment group was 82% ( 18 22), compared with a 57% ( 4 7) complete response rate for seven patients in the palliative group who received low dose TSEB (
Original language | English (US) |
---|---|
Pages (from-to) | 1333-1339 |
Number of pages | 7 |
Journal | International Journal of Radiation Oncology, Biology, Physics |
Volume | 18 |
Issue number | 6 |
DOIs | |
State | Published - 1990 |
Externally published | Yes |
Keywords
- Complete response
- Cutaneous T-cell lymphoma
- Mechlorethamine hydrochloride
- Total skin electron beam radiation
ASJC Scopus subject areas
- Oncology
- Radiology Nuclear Medicine and imaging
- Radiation